Skip to main content

Metastatic prostate cancer

Prostate cancer cells
Prostate cancer cells
Wellcome Library, London

Metastatic prostate cancer (MPC) is by most measures a devastating disease and is the second leading cause of cancer death among men. Determining life expectancy when diagnosed is not a definite science; some Oncologists will tell you that the average period is five years from the date of onset, not the date of diagnosis. This is in large part because the beginning of the disease offer no specific symptoms, hence certain test that can detect factors related to prostate cancer are largely ignored.

The overall 5-year survival rate for MPC is ninety-eight percent. In other words, 98 men out of 100 with MPC survive past 5 years; the greater number of years passed decreases the rate of survival.

Survival rates are divided into 2 sections; disease free survival rate and progression free survival rate. Disease free survival means just that, you are free of cancer. Progression free refers to people who still have cancer, but has not increased in size or activity; it lies dormant.

Understanding that due to individual knowledge of anatomy, physiology, and medical terminology limitations you can find in-depth knowledge regarding life expectancy issues by visiting the Johns Hopkins Special Reports released on September 5, 2009.

With MPC, you will usually have a set of three physicians; the Oncologist, Urologist, and your Pain Management Specialist all highly specialized in their respective fields. Your family physician would know of these specialist and which have the best working relationships and most importantly a common communication thread or network.